A target-focused library is a screening collection of compounds specifically tailored to modulate the function of a particular target or a protein family. These libraries not only reduce waste by eliminating compounds that are unlikely to bind to target proteins, but often lead to the increased potency and specificity of binders, as demonstrated for c-Src kinase. Compared to large and diverse screening libraries, using relatively small and targeted collections significantly improves the odds of finding potential drug candidates, thus further reduces the costs of drug discovery.
Cat No. | product name | ||
---|---|---|---|
L2600 | Neuronal Signaling Compound Library | A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | 2540 compounds |
L2300 | Ion Channel Inhibitor Library | A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | 946 compounds |
L9100 | Phosphatase Inhibitor Library | A collection of 80 phosphatase inhibitors with known activity; | 80 compounds |
L2000 | Inhibitor Library | A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | 7618 compounds |
L1310 | Cytoskeletal Signaling Pathway Compound Library | A unique collection of 773 cytoskeleton-related compounds, can be used for HTS and HCS; | 773 compounds |
L1580 | GPCR Compound Library Plus | Well-chosen 338 GPCR targeting compounds with unique structures; | 338 compounds |
L9700 | Endoplasmic Reticulum Stress Compound Library | A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | 193 compounds |
L1600 | Kinase Inhibitor Library | A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | 2230 compounds |
L2200 | Tyrosine Kinase Inhibitor Library | A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | 746 compounds |
L1400 | MAPK Inhibitor Library | A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | 367 compounds |
L3700 | JAK-STAT Compound Library | A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | 256 compounds |
L7300 | Potassium Channel Blocker Library | A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | 160 compounds |
L1100 | Protease Inhibitor Library | A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | 344 compounds |
L8710 | Cuproptosis Compound Library | TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | 411 compounds |
L1300 | PI3K-AKT-mTOR Compound Library | A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | 425 compounds |
L2610 | Neurotransmitter Receptor Compound Library | A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | 1513 compounds |
L1200 | Epigenetics Compound Library | Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | 960 compounds |
L8500 | HIF-1 Signaling Pathway Compound Library | A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; | 1352 compounds |
L9000 | Apoptosis Compound Library | A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | 1796 compounds |
L7200 | Calcium Antagonist Library | A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | 143 compounds |
L1610 | FDA-Approved Kinase Inhibitor Library | Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research. | 280 compounds |
L4800 | Angiogenesis related Compound Library | A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | 1370 compounds |
L9420 | Exosome Compound Library | 54 exosome-related compounds that can be used for high-throughput and high-content screening. | 54 compounds |
L2700 | Adrenergic Receptor-Targeted Compound Library | A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | 219 compounds |
L8720 | Pyroptosis Compound Library | 1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | 1077 compounds |
L8700 | Ferroptosis Compound Library | A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | 800 compounds |
L4300 | Wnt/Hedgehog/Notch Compound Library | A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | 240 compounds |
L3200 | Autophagy Compound Library | A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | 1248 compounds |
L1510 | Nuclear Receptor Compound Library | A unique collection of 546 nuclear receptor signaling targeted compounds for high throughput and high content screening; | 546 compounds |
L4100 | TGF-beta/Smad Compound Library | A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | 180 compounds |
L3600 | Cytokine Inhibitor Library | A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | 613 compounds |
L7600 | Chemokine Inhibitor Library | A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | 59 compounds |
L8100 | Cell Cycle Compound Library | A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | 695 compounds |
L5300 | Mitochondria-Targeted Compound Library | A unique collection of 830 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | 830 compounds |
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | 155 compounds |
L7400 | Sodium Channel Blocker Library | A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening; | 128 compounds |
L1120 | AMPK-Targeted Compound Library | 80 well-chosen unique AMPK-targeted small molecules; | 80 compounds |
L1110 | Microtubule-Targeted Compound Library | A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS; | 80 compounds |
L1500 | GPCR Compound Library | A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | 1633 compounds |
L3800 | NF-κB Signaling Compound Library | A unique collection of 740 compounds targeting NF-κB signaling for high throughput screening and high content screening; | 740 compounds |
L8600 | Ubiquitination Compound Library | A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening; | 214 compounds |
L3900 | DNA Damage & Repair Compound Library | A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | 937 compounds |
L2800 | Serotonin Receptor-Targeted Compound Library | A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | 275 compounds |
L3510 | Methylation Compound Library | 131 methylation-related compounds that can be used for high-throughput and high-content screening. | 131 compounds |